Insulin-Like Growth Factor-I Induces Chemoresistence to Docetaxel by Inhibiting miR-143 in Human Prostate Cancer

Oncotarget- United States

doi 10.18632/oncotarget.22362

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

Impact Journals, LLC

Related search

Insulin-Like Growth Factor-I and Prostate Cancer: A Meta-Analysis

British Journal of Cancer
Cancer ResearchOncology
2001English

Insulin-Like Growth Factor-1 Alters Apoptotic Signalling in Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2000English

Insulin-Like Growth Factor I Stimulates Motility in Human Neuroblastoma Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Gastrointestinal Absorption of Recombinant Human Insulin-Like Growth Factor-I

Drug Metabolism and Pharmacokinetics
1996English

Insulin-Like Growth Factor-I Induces Cyclooxygenase-2 Expression via PI3K, MAPK and PKC Signaling Pathways in Human Ovarian Cancer Cells☆

Cellular Signalling
Cell Biology
2007English

Expression of Platelet-Derived Growth Factor-C and Insulin-Like Growth Factor I in Hepatic Stellate Cells Is Inhibited by miR-29

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2012English

Fucoidan Downregulates Insulin-Like Growth Factor-I Receptor Levels in HT-29 Human Colon Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

The Insulin-Like Growth Factor System in Cancer

Endocrinology and Metabolism Clinics of North America
EndocrinologyMetabolismDiabetes
2012English

Recombinant Human Insulin-Like Growth Factor I (rhIGF I) Reduces Hyperglycaemia in Patients With Extreme Insulin Resistance

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy